XPO1 inhibitor KPT-330 disrupts the core transcriptional regulatory circuitry of dedifferentiated liposarcoma by modulating the translation process
16 April 2026 at 08:00
Oncogene, Published online: 16 April 2026; doi:10.1038/s41388-026-03794-w
XPO1 inhibitor KPT-330 disrupts the core transcriptional regulatory circuitry of dedifferentiated liposarcoma by modulating the translation process